To discover more potent EGFR-TKI chemosensitizers, we performed drug screening and identified betulinic acid (BA) as a promising wt-EGFR inhibitor that can block the activation of EGFR in wt-EGFR NSCLC cell lines. This evidence concerns the gene EGFR and non-small cell lung carcinoma.